Search

Search Constraints

You searched for: Author/Creator Scalone, Simona

Search Results

1. Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial. Issue 3 (March 2023)

2. Clinical validity of a DPYD‐based pharmacogenetic test to predict severe toxicity to fluoropyrimidines. Issue 12 (14th July 2015)

3. Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva. Issue 11 (30th September 2020)

4. Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva. Issue 11 (November 2020)

5. Multicenter Phase 2 Study of Combined Gemcitabine and Epirubicin as Second-Line Treatment for Patients With Advanced Ovarian Cancer. Issue 6 (1st July 2010)

6. Retreatment with Trastuzumab after Progression on Lapatinib-Based Therapy in Heavily Pretreated HER2-Positive Metastatic Breast Cancer: A Single-Institution Experience. Issue 6 (November 2014)

7. TP003/#1533 MITO CERV3_phase II study on carboplatin-paclitaxel-pembrolizumab in neoadjuvant treatment of locally advanced cervical cancer. (4th December 2022)